Videos

As part of a panel discussion on health care costs and the drug industry, John Vernon and Joseph Golec talked about their book Pharmaceutical Price Regulation: Public Perceptions, Economic R…

The House Oversight and Government Reform Committee held a hearing titled “Should FDA Food and Drug Administration Drug and Medical Device Regulation Bar State Liability Claims?” FDA a…

Dr. Paul Offit talked about his book The Cutter Incident: How America’s First Polio Vaccine Led to the Growing Vaccine Crisis, published by Yale University Press. The event in the 1950s now …

Mr. Offit spoke about vaccinations, the history and application of vaccination science, current research and development in the field, and marketing vaccines.

A panel discussion was held about the settlement Merck made with users of its pain reliever Vioxx, which it withdrew from the market in 2004 because of new studies showing increased cardiova…

Sponsored by the Christine Mirzayan Science and Technology Policy Graduate Fellowship Program seminar series, participants in a forum titled, “Direct to Consumer Advertising of Prescription …

The House Government Reform Committee held a hearing on the Food and Drug Administration’s approval process for pharmaceutical drugs. Witnesses also talked about post-approval surveillance o…

Moderated by Mr. Lessner, the panelists argued that the Food and Drug Administration should not control tobacco sales and advertising. They also talked about the need for tort control and wh…

Representatives of drug manufacturers spoke about the potential impact of Medicare legislation on their industry. Among the topics they addressed were the price of drugs, importation from fo…

The Vaccine Evaluation Committee of the Institute of Medicine released a list of recommendations regarding the development, financing, distribution, and use of vaccines. At this panel, hoste…

The American Enterprise Institute hosted a panel discussion on why the United States population is obese. THIS IS A PARTIAL AIRING

Participants talked about advertising and marketing of prescription drugs. Among the issues they addressed were the impact of advertising on consumers and the health care industry, the costs…

John Calfee talked about his view of the pharmaceutical industry and drug prices. He is the author of Prices, Markets, and the Pharmaceutical Revolution, published by AEI Press. He also re…

Participants talked about the Food and Drug Administration regulation of information dissemination and the First Amendment. Among the topics they addressed were recent court cases involving …

Committee members examined different proposals to strengthen Medicare and help seniors gain more affordable access to prescription drugs. Mr. Walker cautioned against the long term fisc…

The panel continued to respond to questions from the committee dealing with the feasibility of the federal government providing cheaper prescription drugs for senior citizens. One such …

American Enterprise Institute sponsored a panel discussion on the relationship between the health care and drug industries. They focused on advanced technologies and new drugs that have affe…

Current news events and political issues were examined through reviews of the morning newspapers; interviews with journalists, newsmakers and legislators; and viewer telephone calls, faxes a…

Participants talked about various proposed new F.D.A. regulations on the tobacco industry, especially on how they market to young people. They examined whether the advantages of further regu…